HHS Report to Suggest Link Between Acetaminophen Use in Pregnancy and Autism
The U.S. Department of Health and Human Services is expected to release a report indicating a potential link between acetaminophen use during pregnancy and autism spectrum disorder, a claim that has been met with skepticism from medical experts.
The U.S. Department of Health and Human Services (HHS) is anticipated to release a report suggesting a potential link between the use of acetaminophen during pregnancy and an increased risk of autism spectrum disorder (ASD) in children. This forthcoming report, expected later this month, also proposes that folinic acid, a derivative of folate, may offer therapeutic benefits for managing certain autism symptoms.
Medical experts have expressed skepticism regarding these claims. The American College of Obstetricians and Gynecologists continues to recommend acetaminophen as the first-line treatment for pain and fever during pregnancy, emphasizing its safety when used appropriately.
The HHS has cautioned that any assertions about the report's contents are speculative until its official release. A spokesperson stated, "Until we release the final report, any claims about its contents are nothing more than speculation."
Shares of Kenvue, the parent company of Tylenol, declined by 9.4% following news of the anticipated report, reflecting investor concerns over potential public health implications.
The medical community continues to advocate for evidence-based guidelines and advises pregnant women to consult healthcare providers before using any medication.